IIM
ZBIO

INTECH Investment Management’s Zenas BioPharma ZBIO Stock Holding History

INTECH Investment Management’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,863
Closed -$322K – 2386
2025
Q4 		$322K Buy
+8,863
New +$291K ﹤0.01% 1729
2025
Q3 		– Sell
-13,206
Closed -$128K – 2540
2025
Q2 		$128K Buy
13,206
+1,607
+14% +$15.7K ﹤0.01% 2229
2025
Q1 		$91.6K Buy
+11,599
New +$90.8K ﹤0.01% 2334

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return

INTECH Investment Management's ZBIO Position: Q1 2026 in Review

INTECH Investment Management sold out of Zenas BioPharma (ZBIO) in Q1 2026, closing a stake of 8,863 shares — an estimated $322K sold.

INTECH Investment Management first reported a position in ZBIO in Q1 2025 and held it in 3 quarters. The position peaked at $322K in Q4 2025. 139 funds tracked by Wall St. Rank hold ZBIO as of Q1 2026.

  • INTECH Investment Management reported no remaining Zenas BioPharma position as of Q1 2026 after selling out during the quarter.
  • INTECH Investment Management sold 8,863 Zenas BioPharma shares in Q1 2026, an estimated $322K.
  • INTECH Investment Management first reported a position in Zenas BioPharma in Q1 2025 and held it in 3 quarters.
  • INTECH Investment Management's Zenas BioPharma position peaked at $322K in Q4 2025.
  • 139 funds tracked by Wall St. Rank held Zenas BioPharma as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.